Analgesic Effect of Intravenous Lidocaine in Femoral Fractures
Phase 3
Recruiting
- Conditions
- Femoral bone fracture.Fracture of femur
- Registration Number
- IRCT20231213060355N1
- Lead Sponsor
- Artesh University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Age >= 18 years-old
Femoral bone fracture
Severe pain based on numerical rating scale of pain (NRS) (NRS>=7)
Exclusion Criteria
Age > 70 years-old
Crush injury of limb and open fractures
Acute diseases except of fractures
Pregnancy
Presence or history of cardiac block or bradycardia
Presence or history of seizure
Neuromuscular diseases
Neuropathic disease
Diabetes
History of consumption of analgesic or anti-inflammatory drugs
History of opioids consumption
Allergic history of lidocaine and pethidine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umerical Rating Scale of Pain. Timepoint: Before drug administration, 10, 20, 30, 40, 50, 60 minutes after drug administration. Method of measurement: Visual Analogue Scale (VAS) for Pain.
- Secondary Outcome Measures
Name Time Method Drug adverse events. Timepoint: During the 4 hours after drug administration. Method of measurement: Vital sign monitoring and evaluating the signs and symptoms.